Kevin Marsh

Iron deficiency and malaria among children living on the coast of Kenya.Nyakeriga AM, Troye-Blomberg M, Dorfman JR, Alexander ND, Back R, Kortok M, Chemtai AK, Marsh K, Williams TN
J Infect Dis, (2004). 190:439-47

A randomised, controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infants.English M, Mohammed S, Ross A, Ndirangu S, Kokwaro G, Shann F, Marsh K
Arch Dis Child, (2004). 89:665-9

The use of cryopreserved mature trophozoites in assessing antibody recognition of variant surface antigens of Plasmodium falciparum-infected erythrocytes.Kinyanjui SM, Howard T, Williams TN, Bull PC, Newbold CI, Marsh K
J Immunol Methods, (2004). 288:9-18

Pathophysiology of severe malaria in children.Maitland K, Marsh K
Acta Trop, (2004). 90:131-40

Transient cross-reactive immune responses can orchestrate antigenic variation in malaria.Recker M, Nee S, Bull PC, Kinyanjui S, Marsh K, Newbold C, Gupta S
Nature, (2004). 429:555-8

Improving malaria home treatment by training drug retailers in rural Kenya.Marsh VM, Mutemi WM, Willetts A, Bayah K, Were S, Ross A, Marsh K
Trop Med Int Health, (2004). 9:451-60

WHO, the Global Fund, and medical malpractice in malaria treatment.White N, Nosten F, Bjorkman A, Marsh K, Snow RW
Lancet, (2004). 363:1160

Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L
Lancet, (2004). 363:283-9

Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria.Mithwani S, Aarons L, Kokwaro GO, Majid O, Muchohi S, Edwards G, Mohamed S, Marsh K, Watkins W
Br J Clin Pharmacol, (2004). 57:146-52

Malaria.Marsh K, Makani J
Principles of Medicine in Africa, (2004). :

The effects of untreated bednets on malaria infection and morbidity on the Kenyan coast.Mwangi TW, Ross A, Marsh K, Snow RW
Trans R Soc Trop Med Hyg, (2003). 97:369-72

Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa.Ochong E, Nzila A, Kimani S, Kokwaro G, Mutabingwa T, Watkins W, Marsh K
Malar J, (2003). 2:46

Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection.Flanagan KL, Mwangi T, Plebanski M, Odhiambo K, Ross A, Sheu E, Kortok M, Lowe B, Marsh K, Hill AV
Am J Trop Med Hyg, (2003). 68:421-30

Chemosensitization of Plasmodium falciparum by probenecid in vitro.Nzila A, Mberu E, Bray P, Kokwaro G, Winstanley P, Marsh K, Ward S
Antimicrob Agents Chemother, (2003). 47:2108-12

Diagnosis of pneumococcal pneumonia by psaA PCR analysis of lung aspirates from adult patients in Kenya.Scott JA, Marston EL, Hall AJ, Marsh K
J Clin Microbiol, (2003). 41:2554-9

Severe P. falciparum malaria in Kenyan children: evidence for hypovolaemia.Maitland K, Levin M, English M, Mithwani S, Peshu N, Marsh K, Newton CR
QJM, (2003). 96:427-34

Hypothetical performance of syndrome-based management of acute paediatric admissions of children aged more than 60 days in a Kenyan district hospital.English M, Berkley J, Mwangi I, Mohammed S, Ahmed M, Osier F, Muturi N, Ogutu B, Marsh K, Newton CR
Bull World Health Organ, (2003). 81:166-73

Management of severe malaria: implications for research.Marsh K
Br J Clin Pharmacol, (2003). 55:460-3

Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description.Makani J, Matuja W, Liyombo E, Snow RW, Marsh K, Warrell DA
QJM, (2003). 96:355-62

Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens.Kinyanjui SM, Bull P, Newbold CI, Marsh K
J Infect Dis, (2003). 187:667-74